In focus · trending topic

blood cancer

19 stories · following the connections

Kura Oncology Provides Regulatory Update on Tipifarnib and Reports Fourth Quarter and Full Year 2017 Financial Results

By Nasdaq OMXMar 12, 2018, 8:05 PM UTC

Kura Oncology Added to Nasdaq Biotechnology Index

By Nasdaq OMXDec 18, 2017, 12:30 PM UTC

Kura Oncology Development Candidate KO-539 Shows Robust Preclinical Anti-Tumor Activity in NPM1- and DNMT3A-Mutant AML

By Nasdaq OMXOct 28, 2017, 4:30 PM UTC

Kura Oncology to Report Second Quarter 2017 Financial Results

By Nasdaq OMXJul 31, 2017, 11:30 AM UTC

Kura Oncology Announces Issuance of U.S. Patent for Lead Product Candidate Tipifarnib in Head and Neck Cancer

By Nasdaq OMXJul 18, 2017, 11:30 AM UTC

Kura Oncology Reports First Quarter 2017 Operational and Financial Results

By Nasdaq OMXMay 15, 2017, 8:07 PM UTC

Kura Oncology Reports First Quarter 2017 Operational and Financial Results

By Nasdaq OMXMay 15, 2017, 8:07 PM UTC

Kura Oncology Reports First Quarter 2017 Operational and Financial Results

By Nasdaq OMXMay 15, 2017, 8:07 PM UTC